Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04000724 · ClinicalTrials.gov registry record · NA
TechStep: Technology-based Stepped Care to Stem Transgender Adolescent Risk Transmission
A NA study, sponsored by Friends Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 254
- Enrollment target
NCT04000724 is a NA study that has completed, run by Friends Research Institute. The registered enrollment target is 254 participants.
The verdict
NCT04000724, a NA study, has completed, sponsored by Friends Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 254 participants
- Enrollment target
Study Summary
TechStep is a three-arm, technology-based randomized controlled trial (RCT), with a stepped care approach, among high-risk HIV-negative transgender feminine, transgender masculine, and gender non-conforming youth and young adults for reducing sexual risk behaviors and increasing pre-exposure prophylaxis (PrEP) uptake. Participants are randomized into one of three conditions for a 6-month intervention: Group 1: culturally relevant theory-based text messages (Text+Step); or, Group 2: culturally relevant mobile-enhanced website (WebApp+Step); or, Group 3: informational website control condition with no theoretically based text messages or WebApp.
Interventions
- BEHAVIORAL Text Messaging (Text+Step)
- BEHAVIORAL WebApp (App+Step)
- BEHAVIORAL Information/No Step
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2019-10-18 |
| Est. Completion | 2022-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04000724
The ClinicalTrials.gov registry entry for NCT04000724 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 254 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Friends Research Institute, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Text Messaging (Text+Step) is the first listed.
NCT04000724 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04000724 about?
NCT04000724 is a clinical study titled "TechStep: Technology-based Stepped Care to Stem Transgender Adolescent Risk Transmission". TechStep is a three-arm, technology-based randomized controlled trial (RCT), with a stepped care approach, among high-risk HIV-negative transgender feminine, transgender masculine, and gender non-conforming youth and young adults for reducing sexual risk behaviors and increasing pre-exposure prophyl...
What is the current status of trial NCT04000724?
This trial is currently completed. It is a NA study. The enrollment target is 254 participants. The study started on 2019-10-18. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT04000724?
The interventions under investigation include: Text Messaging (Text+Step) (BEHAVIORAL), WebApp (App+Step) (BEHAVIORAL), Information/No Step (BEHAVIORAL).
Who is sponsoring clinical trial NCT04000724?
This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.